New business models for clinical development and manufacturing require strategic partnerships among researchers, manufacturers and payers to fully realize the commercial opportunities.
VIDEO: Innovation in an uncertain world
How are cutting-edge biotech companies trying to compete in a global marketplace dealing with drug-price an...
Other content in this Stream
Biotech Startups: Land and conduct a successful investor meeting
Biotech startup companies face many challenges, but one of the most common is landing and conducting meetings with potential investors. The following are pieces of advice from investors on what...
How can startup companies get noticed by potential investors and partners?
Access the industry's premier life science partnering event, BioPharm America™ in Boston September 26–27, 2017, to connect with strategic partners and get your innovation funded. No other event combin
Tissue regeneration: A vital area within regenerative medicine
Guest post by Patricia Reilly, M.S., Head of Intelligence Alliances and Unification, Pharma Intelligence and Nancy Dvorin, Executive Editor, In Vivo Cell and gene therapies often get the lion’s...
The Advocate of Rare Disease Advocates: Remembering Henri Termeer
We were saddened to come to work Monday morning to discover that innovator, industry giant and Genzyme founder Henri Termeer had died. We had the pleasure of working with Termeer over the years as...
Bruce Levine is a man you can thank for your future cell therapy
To call Bruce Levine, PhD, an innovator in the cell and gene therapy space is a gross understatement. He is known for his groundbreaking work in the development and use of synthetic immune cells...
Where to start: How to gain a foothold in the China biopharmaceutical market
The China pharmaceutical market has come of age. With record breaking investments in innovative companies, support from the CFDA, and new product approvals pending, China has entered a new age as...
Health tech innovators pitch business ideas to expert panel at BIO-Europe Spring®
The buzz steadily grew as the Health Tech Competition got underway on the last day of BIO-Europe Spring® March 22 in Barcelona. As delegates filed into the competition room, the energy was...
The Digital Medicine Crystal Ball
How will digital technologies impact disease management and healthcare over the next decade? Find out in the just-released whitepaper, “The Digital Medicine Crystal Ball: Unlocking the Future of...
Rare Disease Foundation CEO cites collaboration, data sharing as keys to progress
An interview with Monica Weldon, President of Bridge the Gap – SYNGAP Education and Research Foundation Houston-based Monica Weldon is a mother, wife, former teacher and a rare disease advocate...
Report findings provide insight into technological innovations and trends in drug development
Knect365 Life Sciences has released a report offering unique insights into the awareness, perceptions and implementation of technological innovations in the drug development industry. Based on a...
BIO-Europe Spring® 2017: Partnerships are key for rare disease drug discovery and development
What kinds of partnerships are key to getting rare disease research out of the lab and to patients as therapies and cures? Wendy White, Board Chairman of Global Genes, discusses her work on behalf of
BIO-Europe Spring® 2017: Sinergium provides gateway to Latin American vaccine and biologics markets
With the Latin American vaccines market forecast to more than quadruple in size from just over USD 150 million to 2015 to just under USD 700 million in 2020, opportunities abound for both homegrown bu
BIO-Europe Spring® 2017: Imanova trims Phase I and IIa trial timelines and costs
Dr. Kevin Cox, CEO of Imanova, the UK-based translational biomedical imaging company, explains to Scrip’s Mike Ward how his company can help biotechs and pharma firms cut the cost of Phase I and IIa t
BIO-Europe Spring® 2017: vitalityDNA plans to keep healthy individuals healthy
Precision medicines, an increased interest in the microbiome and a growing focus on wellness are some of the latest trends gripping the healthcare industry. London-based startup vitalityDNA is combini
BIO-Europe Spring® 2017: Producing monoclonals for at least a tenth of the cost
Dutch antibody technology company BiosanaPharma is offering to make monoclonal antibodies at between 5% and 10% the usual cost of manufacture. Dr. Nettie Buitelaar, the company’s chief business office
Q1 2017 – Advanced Therapies Make a Strong Showing Early in the Year
Guest post by Patricia Reilly, M.S., Head of Intelligence Alliances and Unification, Pharma Intelligence and Nancy Dvorin, Executive Editor, In Vivo Advanced therapy companies started 2017 with a...
Using Partnerships, Hua Medicine Brings Novel Diabetes Drug to Phase III
Li Chen, PhD, co-founded Hua Medicine (Shanghai) six years ago with Ge Li, PhD, founder of WuXi AppTec. The company soon in-licensed global rights to a GKA treatment for type 2 diabetes from...
BIO-Europe Spring® 2017: Stirring the entrepreneurial pot in Europe
Europe is home to many of the biggest pharma companies and the best academic biomedical researchers. But the US is the dominant place with thriving hubs of biotech entrepreneurs, people taking big ris
BIO-Europe Spring® 2017: Infant Bacterial Therapeutics harnesses microbiome to treat preterm babies
By harvesting Lactobacillus reuteri from lactating mothers, Infant Bacterial Therapeutics has developed an approach to treat necrotizing enterocolitis, a major killer of premature babies. Company CEO
BIO-Europe Spring® 2017: Digimed and diagnostics: Market access and new collaborations